110 related articles for article (PubMed ID: 24533506)
21. Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.
Verde F; Aiello EN; Adobbati L; Poletti B; Solca F; Tiloca C; Sangalli D; Maranzano A; Muscio C; Ratti A; Zago S; Ticozzi N; Frisoni GB; Silani V
J Alzheimers Dis; 2023; 95(4):1383-1399. PubMed ID: 37694369
[TBL] [Abstract][Full Text] [Related]
22. Evidence based on Mendelian randomization and colocalization analysis strengthens causal relationships between structural changes in specific brain regions and risk of amyotrophic lateral sclerosis.
Shi J; Wang Z; Yi M; Xie S; Zhang X; Tao D; Liu Y; Yang Y
Front Neurosci; 2024; 18():1333782. PubMed ID: 38505770
[TBL] [Abstract][Full Text] [Related]
23. The association between lifelong personality and clinical phenotype in the FTD-ALS spectrum.
Vinceti G; Carbone C; Gallingani C; Fiondella L; Salemme S; Zucchi E; Martinelli I; Gianferrari G; Tondelli M; Mandrioli J; Chiari A; Zamboni G
Front Neurosci; 2023; 17():1248622. PubMed ID: 37859765
[TBL] [Abstract][Full Text] [Related]
24. Alterations to metabolic hormones in amyotrophic lateral sclerosis and frontotemporal dementia postmortem human tissue.
Atkinson RAK; Collins JM; Sreedharan J; King AE; Fernandez-Martos CM
J Neuropathol Exp Neurol; 2024 Jun; ():. PubMed ID: 38917432
[TBL] [Abstract][Full Text] [Related]
25. Morphometric MRI as a diagnostic biomarker of frontotemporal dementia: A systematic review to determine clinical applicability.
McCarthy J; Collins DL; Ducharme S
Neuroimage Clin; 2018; 20():685-696. PubMed ID: 30218900
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, Timing, and Network Localization of Emergent Visual Creativity in Frontotemporal Dementia.
Friedberg A; Pasquini L; Diggs R; Glaubitz EA; Lopez L; Illán-Gala I; Iaccarino L; La Joie R; Mundada N; Knudtson M; Neylan K; Brown J; Allen IE; Rankin KP; Bonham LW; Yokoyama JS; Ramos EM; Geschwind DH; Spina S; Grinberg LT; Miller ZA; Kramer JH; Rosen H; Gorno-Tempini ML; Rabinovici G; Seeley WW; Miller BL
JAMA Neurol; 2023 Apr; 80(4):377-387. PubMed ID: 36848111
[TBL] [Abstract][Full Text] [Related]
27. Progressive hemiparesis (Mills syndrome) with aphasia in amyotrophic lateral sclerosis.
Bäumer D; Butterworth R; Menke RA; Talbot K; Hofer M; Turner MR
Neurology; 2014 Feb; 82(5):457-8. PubMed ID: 24363135
[TBL] [Abstract][Full Text] [Related]
28. Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status.
Di Napoli J; Arighi A; Conte G; Carandini T; Sacchi L; Arcaro M; Fenoglio C; Sorrentino F; Mercurio M; Pietroboni AM; Giardinieri G; Triulzi F; Galimberti D; Scarpini E; Fumagalli GG
Eur J Neurol; 2024 Feb; 31(2):e16124. PubMed ID: 37933893
[TBL] [Abstract][Full Text] [Related]
29. Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis.
Placek K; Benatar M; Wuu J; Rampersaud E; Hennessy L; Van Deerlin VM; Grossman M; Irwin DJ; Elman L; McCluskey L; Quinn C; Granit V; Statland JM; Burns TM; Ravits J; Swenson A; Katz J; Pioro EP; Jackson C; Caress J; So Y; Maiser S; Walk D; Lee EB; Trojanowski JQ; Cook P; Gee J; Sha J; Naj AC; Rademakers R; ; Chen W; Wu G; Paul Taylor J; McMillan CT
EMBO Mol Med; 2021 Jan; 13(1):e12595. PubMed ID: 33270986
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of research criteria for prodromal frontotemporal dementia.
Benussi A; Premi E; Grassi M; Alberici A; Cantoni V; Gazzina S; Archetti S; Gasparotti R; Fumagalli GG; Bouzigues A; Russell LL; Samra K; Cash DM; Bocchetta M; Todd EG; Convery RS; Swift I; Sogorb-Esteve A; Heller C; van Swieten JC; Jiskoot LC; Seelaar H; Sanchez-Valle R; Moreno F; Laforce RJ; Graff C; Synofzik M; Galimberti D; Rowe JB; Masellis M; Tartaglia MC; Finger E; Vandenberghe R; Mendonça A; Tiraboschi P; Butler CR; Santana I; Gerhard A; Le Ber I; Pasquier F; Ducharme S; Levin J; Sorbi S; Otto M; Padovani A; Rohrer JD; Borroni B;
Alzheimers Res Ther; 2024 Jan; 16(1):10. PubMed ID: 38216961
[TBL] [Abstract][Full Text] [Related]
31. High Risk of Suicide in Behavioral Variant Frontotemporal Dementia.
Zucca M; Rubino E; Vacca A; Govone F; Gai A; De Martino P; Boschi S; Gentile S; Giordana MT; Rainero I
Am J Alzheimers Dis Other Demen; 2019 Jun; 34(4):265-271. PubMed ID: 30558441
[TBL] [Abstract][Full Text] [Related]
32. Altered empathy processing in frontotemporal dementia A task-based fMRI study.
Lindberg O; Li TQ; Lind C; Vestberg S; Almkvist O; Stiernstedt M; Ericson A; Bogdanovic N; Hansson O; Harper L; Westman E; Graff C; Tsevis T; Mannfolk P; Fischer H; Nilsonne G; Petrovic P; Nyberg L; Wahlund LO; Santillo AF;
bioRxiv; 2024 Mar; ():. PubMed ID: 38585830
[TBL] [Abstract][Full Text] [Related]
33. Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementia.
Toller G; Cobigo Y; Callahan P; Appleby BS; Brushaber D; Domoto-Reilly K; Forsberg LK; Ghoshal N; Graff-Radford J; Graff-Radford NR; Grossman M; Heuer HW; Kornak J; Kremers W; Lapid MI; Leger G; Litvan I; Mackenzie IR; Pascual MB; Ramos EM; Rascovsky K; Rojas JC; Staffaroni AM; Tartaglia MC; Toga A; Weintraub S; Wszolek ZK; Boeve BF; Boxer AL; Rosen HJ; Rankin KP;
Alzheimers Dement; 2023 Jul; 19(7):2842-2852. PubMed ID: 36591730
[TBL] [Abstract][Full Text] [Related]
34. Inorganic polyphosphate: from basic research to diagnostic and therapeutic opportunities in ALS/FTD.
Garcés P; Amaro A; Montecino M; van Zundert B
Biochem Soc Trans; 2024 Feb; 52(1):123-135. PubMed ID: 38323662
[TBL] [Abstract][Full Text] [Related]
35. Differences in peripheral immune system gene expression in frontotemporal degeneration.
Sawyer RP; Hill EJ; Yokoyama J; Medvedovic M; Ren Y; Zhang X; Choubey D; Shatz RS; Miller B; Woo D
Medicine (Baltimore); 2022 Jan; 101(3):e28645. PubMed ID: 35060553
[TBL] [Abstract][Full Text] [Related]
36. Impaired acquisition rates of probabilistic associative learning in frontotemporal dementia is associated with fronto-striatal atrophy.
Dalton MA; Weickert TW; Hodges JR; Piguet O; Hornberger M
Neuroimage Clin; 2012; 2():56-62. PubMed ID: 24179759
[TBL] [Abstract][Full Text] [Related]
37. Building a Case for Withaferin A as a Treatment for FTD/ALS Syndromes.
Borchelt DR
Neurotherapeutics; 2021 Jan; 18(1):284-285. PubMed ID: 33398802
[No Abstract] [Full Text] [Related]
38. [Resistance to the use of a wheelchair and gait aids by patients with amyotrophic ALS: Learned beliefs and attitudes].
Manrique Rabelo CM
Rehabilitacion (Madr); 2024; 58(1):100830. PubMed ID: 38128171
[No Abstract] [Full Text] [Related]
39. An unusual ALS onset with hyperhidrosis as first clinical manifestation.
Giugno A; Nisticò R; Barone S; Cretella M; Valentino P
Neurol Sci; 2022 Nov; 43(11):6571-6572. PubMed ID: 35907109
[No Abstract] [Full Text] [Related]
40. Brain atrophy pattern in patients with mild cognitive impairment: MRI study.
Calandrelli R; Panfili M; Onofrj V; Tran HE; Piludu F; Guglielmi V; Colosimo C; Pilato F
Transl Neurosci; 2022 Jan; 13(1):335-348. PubMed ID: 36250040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
